Enterobiome
Gyeongju
About Enterobiome
Enterobiome is a biopharmaceutical company that develops microbiome drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2024)
- Website: enterobiome.com
- Phone: +82 031 968 7456
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/enterobiome-69641 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.